"Shping 2" different cellular localizations - a potential new player






































Shp-2 is a ubiquitously expressed protein tyrosine 
phosphatase, which contains two N-terminal Src 
homology 2 (SH2) domains and a C-terminal protein 
tyrosine phosphatase domain. Several years of research 
established an important role for cytosolic Shp-2. It is 
known to modulate different pathways involved in cell 
growth, cell development, tissue inflammation and 
cellular chemotaxis due to its well described function to 
dephosphorylate receptor tyrosine kinases (reviewed in 
[1]). However, over the last years it has become clear 
that Shp-2 is also localized in the nucleus and in the 
mitochondria where it exerts different functions. 
 
In 2002 Chughtai et al reported a nuclear localization of 



































































counteracts  the  oxidative  stress  dependent  nuclear  export  of  Telomerase  Reverse  Transcriptase  (TERT)  mediated  by
members of the Src kinase family, a process leading to replicative senescence. For the recently found mitochondrial Shp‐2
an involvement in the regulation of the cellular redox balance is discussed. Shp‐2 shows the ability to regulate reactive





of transcription 5 (STAT5). The stimulation of 
mammary cells with prolactin induced the nuclear 
translocation of Shp-2 in a complex with STAT5. 
Formation of this complex and tyrosine phosphorylation 
of STAT5 in response to prolactin requires the SH2 
domain closer to the C-terminus and the catalytic 
activity of Shp-2. The authors speculated that the 
nuclear Shp-2/STAT5 complex binds to DNA and 
regulates transcription of milk protein genes [2], 
demonstrating a transcriptional regulation by nuclear 
Shp-2. This provided for the first time evidence for a 
function of Shp-2 besides dephosphorylation. In 
contrast, it has been demonstrated that Shp-2 
dephosphorylates STAT1 at tyrosine and serine residues 
in the nucleus and thereby inhibits its transcriptional 
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mode of its action Shp-2 differently regulates specific 
STAT proteins. Just recently, we discovered that nuclear 
Shp-2 seems to be involved in aging processes. Previous 
findings from our group demonstrated that the enzyme 
Telomerase Reverse Transcriptase (TERT), which is 
important for maintaining telomere length and known to 
delay aging processes, when overexpressed, is tyrosine 
phosphorylated by Src kinases in the nucleus under 
conditions of oxidative stress in several cell types, 
including endothelial cells [4, 5]. This tyrosine 
phosphorylation triggers nuclear export of TERT. Taking 
into account that cytosolic Shp-2 and the cytosolic Src 
kinase family can regulate and antagonize each other 
under certain conditions, we hypothesized that a nuclear 
Shp-2 also exists in endothelial cells and that this may 
counteract the Src kinase dependent nuclear export of 
TERT. Indeed, ablation of endogenous Shp-2 results in 
increased tyrosine phosphorylation of nuclear TERT and 
a reduction of telomerase activity in the nucleus. 
Moreover, overexpression of Shp-2 inhibited oxidative 
stress induced tyrosine phosphorylation and export of 
TERT from the nucleus. It has to be noted that this 
process requires the catalytic activity of Shp-2, since the 






























vent nuclear export of TERT. Interestingly, 
overexpression of Shp-2(C459S) reduced nuclear 
telomerase activity already under basal conditions. This 
effect was dependent on tyrosine 707 in TERT [6]. One 
possible explanation for the nuclear export of TERT 
induced by Shp-2(C459S) under basal conditions could 
be the significant increase in reactive oxygen species 
(ROS), which are known to activate the Src kinase 
family. Indeed, ROS formation is enhanced upon 
overexpression of Shp-2(C459S) in endothelial cells 
(Figure 1). These data point to a regulatory role of Shp-2 
in the redox balance of cells. 
 
ROS are important signalling molecules for cellular 
signal transduction. An imbalance of the redox status 
with a reduced antioxidative capacity and an increased 
ROS production has been described to play an 
important role in aging processes as well as in several 
diseases. Increased ROS can directly damage DNA, 
proteins and membrane lipids. This leads among others 
to damage of the electron transport chain, which results 
in an increased formation of ROS which in turn cause 
further damage to DNA, proteins and lipids. This 
vicious cycle seems to play an important role in aging 































































































































































www.impactaging.com                   666                                              AGING, July    2009, Vol.1 No.7Therefore, controlling ROS formation seems to be an 
interesting tool in delaying aging processes. It is 
tempting to speculate that nuclear Shp-2 plays an 
important role in nuclear based aging processes by 
reducing export of TERT from the nucleus and by 
reducing ROS formation (figure 1). However, we have 
also new hints, that Shp-2 may affect mitochondrial 
ROS production and thus, aging processes which 
depend on reduced mitochondrial function. New data 
from our laboratory demonstrate that overexpression of 
Shp-2 decreases not only ROS production in the cytosol 
(Figure 1) but also in the mitochondria (Figure 2). 
Moreover, preliminary results suggest that ablation of 
Shp-2 increases mitochondrial ROS levels. To 
specifically measure mitochondrial ROS levels, we used 
mitosox, a redox-sensitive dye, which first has to enter 
mitochondria before it can react with ROS. One can 
speculate, that the observed reduction of 
mitochondrially derived ROS is connected to a 
localization of Shp-2 in the mitochondria. Indeed, Salvi 
et al detected a tyrosine phosphatase activity in the 
mitochondria of rat brains and identified the responsible 
phosphatase as Shp-2 [8]. Recently, Arachiche et al 
showed also the mitochondrial localization of Shp-2 and 
of the tyrosine kinase Src, which is regulated by Shp-2 
[9]. They demonstrated that the complexes of the 
respiratory chain are substrates of Src, which indicates 
that respiratory chain activity is partially dependent on 
tyrosine phosphorylation. Since Shp-2 is an important 
regulator of Src, Shp-2 is possibly involved in 
regulation of mitochondrial activity. In line with these 
findings, we recently demonstrated that TERT is 
localized in the mitochondria and importantly 
contributes to respiratory chain activity [10]. TERT 
deficient mice derived from heterozygous breeding 
pairs, which show no reduction in telomere length and 
thus no premature aging phenotype, demonstrated 
reduced respiratory chain activity in the heart, 
suggesting an important role for TERT in respiration in 
vivo [10]. Given the facts that Src kinase family 
members as well as Shp-2 show mitochondrial 
localization [9], it is tempting to speculate that similar 
to nuclear TERT also mitochondrial TERT is positively 
regulated by Shp-2 in these organelles. This could 
implicate that mitochondrial Shp-2 in concert with 
TERT accounts for an intact respiratory chain activity 
and for reduced mitochondrial ROS formation. 
Therefore, mitochondrial Shp-2 and TERT could break 
the above mentioned vicious cycle and thereby may 
delay aging processes, which depend on mitochondrial 
dysfunction. 
 
In summary, Shp-2 has the potential to be a yet 
unknown new important key player in aging processes. 
Its regulatory function seems to be dependent on its 
localization within the cell (Figure 3). Nuclear localized 
Shp-2 counteracts replicative senescence induced by 
nuclear TERT export and mitochondrial Shp-2 could 
delay aging processes induced by elevated ROS levels. 
Therefore, Shp-2 could be an important target for the 
therapy of diseases connected to aging processes. 
However, therapeutic interventions aimed at the 
activation of Shp-2 should take into account the 




This work was supported by Deutsche Forschungs-
gemeinschaft SFB 728 B5 and HA2868/2-3 to J.H.  
 
CONFLICT OF INTERESTS STATEMENT 
 
The authors of this manuscript have no conflict of 




1.  Chong  ZZ,  Maiese  K.  The  Src  homology  2  domain  tyrosine 
phosphatases  SHP‐1  and  SHP‐2:  diversified  control  of  cell 
growth, inflammation, and injury. Histol Histopathol. 2007; 22: 
1251‐1267. 


































www.impactaging.com                   667                                              AGING, July    2009, Vol.1 No.710. Haendeler J, Dröse S, Büchner N, Jakob S, Altschmied J, Goy 
C,  Spyridopoulos  I,  Zeiher  AM,  Brandt  U,  Dimmeler  S. 
Mitochondrial  telomerase  reverse  transcriptase  binds  to  and 






www.impactaging.com                   668                                              AGING, July    2009, Vol.1 No.7